These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33174645)

  • 1. A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: Case report.
    Piccolo A; Pensa C; Zangrilli A; Bavetta M; Diluvio L; Bianchi L
    Dermatol Ther; 2020 Nov; 33(6):e14526. PubMed ID: 33174645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional pentoxifylline injection in localized alopecia areata.
    El-Taweel AI; Akl EM
    J Cosmet Dermatol; 2019 Apr; 18(2):602-607. PubMed ID: 30302901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe alopecia areata with intralesional steroid injections.
    Chang KH; Rojhirunsakool S; Goldberg LJ
    J Drugs Dermatol; 2009 Oct; 8(10):909-12. PubMed ID: 19852119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional corticosteroid-induced hypopigmentation and atrophy.
    Weinhammer AP; Shields BE; Keenan T
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of different concentrations of intralesional triamcinolone acetonide for alopecia areata: A systematic review and meta-analysis.
    Yee BE; Tong Y; Goldenberg A; Hata T
    J Am Acad Dermatol; 2020 Apr; 82(4):1018-1021. PubMed ID: 31843657
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid.
    Taliaferro K; Crawford A; Jabara J; Lynch J; Jung E; Zvirbulis R; Banka T
    Clin Orthop Relat Res; 2018 Jul; 476(7):1420-1425. PubMed ID: 29533245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear cutaneous hypopigmentation and atrophy associated with intralesional steroid injection: A rarely described adverse reaction.
    Magri F; Iacovino C; Vittori J; Pranteda G
    Dermatol Ther; 2019 Jul; 32(4):e12941. PubMed ID: 31012196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia following intralesional corticosteroid injection in a patient with type I diabetes mellitus.
    Fleming P; Drazek L; Shaw JC
    J Cutan Med Surg; 2014; 18(4):275-6. PubMed ID: 25008445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional betamethasone
    de Sousa VB; Arcanjo FP; Aguiar F; Vasconcelos J; Oliveira AF; Honório A; Pontes J
    J Dermatolog Treat; 2022 Mar; 33(2):875-877. PubMed ID: 32594786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacromial triamcinolone acetonide, hyaluronic acid and saline injections for shoulder pain an RCT investigating the effectiveness in the first days.
    Penning LI; de Bie RA; Walenkamp GH
    BMC Musculoskelet Disord; 2014 Oct; 15():352. PubMed ID: 25341673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel step-up regimen of intralesional triamcinolone acetonide in scalp alopecia areata based on a double-blind randomized controlled trial.
    Rajan M B; Bhardwaj A; Singh S; Budania A; Bains A; Thirunavukkarasu P; Kumar-M P
    Dermatol Ther; 2021 Jan; 34(1):e14555. PubMed ID: 33210434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear Leucoderma Following Intralesional Steroid Injection.
    Beena A; Sapam R; Devi GC; Lnu A; Leishangthem J
    Cureus; 2024 May; 16(5):e60783. PubMed ID: 38903338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eyelid Fat Atrophy and Depigmentation After an Intralesional Injection of Triamcinolone Acetonide to Treat Chalazion.
    Park J; Chang M
    J Craniofac Surg; 2017 May; 28(3):e198-e199. PubMed ID: 28468185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional methotrexate versus triamcinolone acetonide for localized alopecia areata treatment: A randomized clinical trial.
    Hamdino M; El-Barbary RA; Darwish HM
    J Cosmet Dermatol; 2022 Feb; 21(2):707-715. PubMed ID: 33749975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide.
    Teelucksingh S; Balkaran B; Ganeshmoorthi A; Arthur P
    Ann Trop Paediatr; 2002 Mar; 22(1):89-91. PubMed ID: 11926057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branch-shaped Cutaneous Hypopigmentation and Atrophy after Intralesional Triamcinolone Injection.
    Jang WS; Park J; Yoo KH; Han TY; Li K; Seo SJ; Hong CK
    Ann Dermatol; 2011 Feb; 23(1):111-4. PubMed ID: 21738379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study between fractional carbon dioxide laser vs intralesional steroid injection in treatment of alopecia areata.
    El-Husseiny R; Elframawy S; Abdallah M
    Dermatol Ther; 2020 Jul; 33(4):e13742. PubMed ID: 32478930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branching hypopigmentation following intralesional corticosteroid injection: Case report and review of the literature.
    Bjorklund KA; Fernandez Faith E
    Pediatr Dermatol; 2020 Jan; 37(1):235-236. PubMed ID: 31997450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perilymphatic subcutaneous fat atrophy and cutaneous depigmentation after periocular triamcinolone acetonide injection in a child.
    Say EA; Shields CL; Bianciotto C; Shields JA
    J AAPOS; 2011 Feb; 15(1):107-8. PubMed ID: 21397819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata.
    Ganjoo S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2013; 79(3):408-17. PubMed ID: 23619446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.